The Minimal Clinically Important Difference for the "Patient Activation Measure".

ABSTRACT:

Introduction

Patient activation is the knowledge, skills, and confidence required to manage one's own health. In chronic kidney disease (CKD), the most frequently used measure of patient activation is the 13-item "Patient Activation Measure" (PAM-13). To help better determine an intervention's clinical effectiveness, trials can interpret changes in patient-derived outcomes using the "minimal clinically important difference" (MCID), defined as the smallest change important to the patient. In this study, we establish the MCID and minimal detectable change (MDC) for PAM-13 in patients with nondialysis CKD using established methodology.

Methods

This was a retrospective secondary analysis of a randomized control trial investigating the effects of a digital health intervention in

SUBMITTER: Wilkinson TJ 

PROVIDER: S-EPMC12266269 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature